Cite

HARVARD Citation

    Dreesen, E. et al. (2020). A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. Inflammatory bowel diseases. 26 (4), p. . [Online]. 
  
Back to record